Ahmed Salah Fayed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ahmed Salah Fayed has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Maha Abdelmonem Hegazy
Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt
2 shared publications Mostafa A. Shehata
2 shared publicationsNagiba Y. Hassan
2 shared publicationsSoheir A. Weshahy
2 shared publicationsAhmed Ashour
Pharmaceutical Chemistry Department, Faculty of Pharmacy, Misr International University, Cairo, Egypt
1 shared publication- Ann Van Schepdael
Pharmaceutical Analysis, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven—University of Leuven, Herestraat 49, O&N2, PB 923, 3000 Leuven, Belgium
1 shared publication
Latest Publications
- 7 January 2023
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 62 (1) , 85-91
Expeditive Chromatographic Methods for Quantification of Solifenacin Succinate along with its Official Impurity as the Possible Acid Degradation Product
Two selective stability-indicating procedures were adopted for the quantification of Solifenacin succinate (SOL) along with its acid degradant, in its powder form or in pharmaceutical tablet. Under stress conditions, the acid degradation pathway of SOL was investigated, its official impurity (SOL imp-A) was obtained as the possible acid degradation product, also. A densitometric technique based on the separation of SOL from SOL imp-A employing HPTLC plates prelaminated with silica gel 60 F254 as the stationary phase and a developing solution containing methanol:chloroform:ammonia (8:1:1, v/v/v) and UV scanning of the developed bands at 220 nm. Linear regression analysis data for the calibration plot of SOL showed perfect linear relationships throughout the range of concentration 10–60 μg/band. A reversed phase C18 analytical column (4.6 × 250 mm, 5 μm) was also used to separate the mixture at a flow rate of 1 mL/min, using acetonitrile:0.05 M phosphate buffer (70:30, v/v) as the mobile phase and phosphoric acid to set pH = 3.5. Quantification was obtained at 220 nm using peak area and linear calibration curve across a concentration range of 10–70 μg/mL. The recommended procedures were applied to the existing dosage form, and they generated satisfactory results.
- 7 January 2023
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 62 (1) , 85-91
Expeditive Chromatographic Methods for Quantification of Solifenacin Succinate along with its Official Impurity as the Possible Acid Degradation Product
Two selective stability-indicating procedures were adopted for the quantification of Solifenacin succinate (SOL) along with its acid degradant, in its powder form or in pharmaceutical tablet. Under stress conditions, the acid degradation pathway of SOL was investigated, its official impurity (SOL imp-A) was obtained as the possible acid degradation product, also. A densitometric technique based on the separation of SOL from SOL imp-A employing HPTLC plates prelaminated with silica gel 60 F254 as the stationary phase and a developing solution containing methanol:chloroform:ammonia (8:1:1, v/v/v) and UV scanning of the developed bands at 220 nm. Linear regression analysis data for the calibration plot of SOL showed perfect linear relationships throughout the range of concentration 10–60 μg/band. A reversed phase C18 analytical column (4.6 × 250 mm, 5 μm) was also used to separate the mixture at a flow rate of 1 mL/min, using acetonitrile:0.05 M phosphate buffer (70:30, v/v) as the mobile phase and phosphoric acid to set pH = 3.5. Quantification was obtained at 220 nm using peak area and linear calibration curve across a concentration range of 10–70 μg/mL. The recommended procedures were applied to the existing dosage form, and they generated satisfactory results.
- 4 April 2016
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (45) , 39409-39423
Chromatographic analysis of multicomponent mixture of vitamins B1, B6, B12, benfotiamine and diclofenac; part II: LC-tandem MS/MS method for simultaneous quantification of five components mixture in pharmaceutical formulations and human plasma
A novel high performance liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) method was established for the simultaneous determination of multivitamins, namely thiamine hydrochloride (B1), pyridoxine (B6), cyanocobalamin (B12) and benfotiamine (BEN) and their co-formulated drug, diclofenac sodium (DIC) using torsemide as internal standard (IS). Chromatographic separation was accomplished on Shimadzu LC-20 AT Series HPLC, equipped with Sunfire C18 column (Waters) (50 × 4.6 mm, 5 μm) using methanol : 0.02 M ammonium acetate (80 : 20, v/v) pH 6.0 for B1, B12, BEN and DIC, while using methanol : acetonitrile : 0.01 M ammonium formate (80 : 10 : 10, v/v/v) pH 6.25 for B6 on separate runs at a flow rate of 1.0 mL min−1. Sample preparation involves extraction with methanol using 30 ng mL−1 of IS. Electrospray ionization (ESI) source was operated in the positive ion mode. The multiple reaction monitoring (MRM) mode on a triple quadrupole mass spectrometer was used to quantify the drugs utilizing the transitions of 265.07/122.10, 170.01/152.20, 678.64/147.01, 467.18/122.10, 296.02/214.20, 348.99/263.90 (m/z) for B1, B6, B12, BEN, DIC and IS, respectively. The proposed method was effectively applied for the analysis of laboratory prepared mixtures, in spiked human plasma as well as in their combined pharmaceutical formulations. A detailed analytical and bioanalytical validation was conducted in compliance with the FDA and ICH guidelines proving the method to be selective, linear, precise and accurate over the concentration ranges of 0.01–20.00, 0.02–50.00, 15.00–500.00, 5.00–500.00 and 10.00–500.00 ng mL−1 for the five compounds, in order. The simplicity and sensitivity of this method allows its use in the quality control of the cited drugs.
- 4 April 2016
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (45) , 39409-39423
Chromatographic analysis of multicomponent mixture of vitamins B1, B6, B12, benfotiamine and diclofenac; part II: LC-tandem MS/MS method for simultaneous quantification of five components mixture in pharmaceutical formulations and human plasma
A novel high performance liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) method was established for the simultaneous determination of multivitamins, namely thiamine hydrochloride (B1), pyridoxine (B6), cyanocobalamin (B12) and benfotiamine (BEN) and their co-formulated drug, diclofenac sodium (DIC) using torsemide as internal standard (IS). Chromatographic separation was accomplished on Shimadzu LC-20 AT Series HPLC, equipped with Sunfire C18 column (Waters) (50 × 4.6 mm, 5 μm) using methanol : 0.02 M ammonium acetate (80 : 20, v/v) pH 6.0 for B1, B12, BEN and DIC, while using methanol : acetonitrile : 0.01 M ammonium formate (80 : 10 : 10, v/v/v) pH 6.25 for B6 on separate runs at a flow rate of 1.0 mL min−1. Sample preparation involves extraction with methanol using 30 ng mL−1 of IS. Electrospray ionization (ESI) source was operated in the positive ion mode. The multiple reaction monitoring (MRM) mode on a triple quadrupole mass spectrometer was used to quantify the drugs utilizing the transitions of 265.07/122.10, 170.01/152.20, 678.64/147.01, 467.18/122.10, 296.02/214.20, 348.99/263.90 (m/z) for B1, B6, B12, BEN, DIC and IS, respectively. The proposed method was effectively applied for the analysis of laboratory prepared mixtures, in spiked human plasma as well as in their combined pharmaceutical formulations. A detailed analytical and bioanalytical validation was conducted in compliance with the FDA and ICH guidelines proving the method to be selective, linear, precise and accurate over the concentration ranges of 0.01–20.00, 0.02–50.00, 15.00–500.00, 5.00–500.00 and 10.00–500.00 ng mL−1 for the five compounds, in order. The simplicity and sensitivity of this method allows its use in the quality control of the cited drugs.
- 1 February 2009
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 49 (2) , 193-200
Separation and determination of clopidogrel and its impurities by capillary electrophoresis
- 1 February 2009
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 49 (2) , 193-200
Separation and determination of clopidogrel and its impurities by capillary electrophoresis
- 5 November 2007
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 45 (3) , 407-416
Validated stability-indicating methods for determination of cilostazol in the presence of its degradation products according to the ICH guidelines
- 5 November 2007
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 45 (3) , 407-416
Validated stability-indicating methods for determination of cilostazol in the presence of its degradation products according to the ICH guidelines
- 1 November 2007
- Published by IMR Press in Die Pharmazie
- Vol. 62 (11) , 830-5
Stability-indicating spectrophotometric and spectrofluorimetric methods for determination of alfuzosin hydrochloride in the presence of its degradation products
Validated stability-indicating spectrophotometric and spectrofluorimetric assays (SIAMs) were developed for the determination of alfuzosin hydrochloride (ALF) in the presence of its oxidative, acid, and alkaline degradation products. Three spectrophotometric methods were suggested for the determination of ALF in the presence of its oxidative degradation product; these included the use of zero order (0D), first order (1D), and third order (3D) spectra. The absorbance was measured at 330.8 nm for (0D) method, while the amplitude of first derivative (1D) method and that of third derivative (3D) method were measured at 354.0 and 241.2 nm, respectively. The linearity ranges were 1.0–40.0 μg/ml for (0D) and (1D) methods, and 1.0–10.0 μg/ml for (3D) method. Two spectrofluorimetric methods were developed, one for determination of ALF in the presence of its oxidative degradation product and the other for its determination in the presence of its acid or alkaline degradation products. The first method was based on measuring the native fluorescence of ALF in deionized water using λexcitation 325.0 nm and λemission 390.0 nm. The linearity range was 50.0–750.0 ng/ml. This method was also used to determine ALF in human plasma with the aid of a suggested solid phase extraction method. The second method was used for determination of ALF via its acid degradation product. The method was based on the reaction of fluorescamine with the primary aliphatic amine group produced on the degradation product moiety. The reaction product was determined spectrofluorimetrically using λexcitation 380.0 nm and λemission 465.0 nm. The linearity range was 100.0–900.0 ng/ml. All methods were validated according to the International Conference on Harmonization (ICH) guidelines, and applied to bulk powder and pharmaceutical formulations.
- 1 November 2007
- Published by IMR Press in Die Pharmazie
- Vol. 62 (11) , 830-5
Stability-indicating spectrophotometric and spectrofluorimetric methods for determination of alfuzosin hydrochloride in the presence of its degradation products
Validated stability-indicating spectrophotometric and spectrofluorimetric assays (SIAMs) were developed for the determination of alfuzosin hydrochloride (ALF) in the presence of its oxidative, acid, and alkaline degradation products. Three spectrophotometric methods were suggested for the determination of ALF in the presence of its oxidative degradation product; these included the use of zero order (0D), first order (1D), and third order (3D) spectra. The absorbance was measured at 330.8 nm for (0D) method, while the amplitude of first derivative (1D) method and that of third derivative (3D) method were measured at 354.0 and 241.2 nm, respectively. The linearity ranges were 1.0–40.0 μg/ml for (0D) and (1D) methods, and 1.0–10.0 μg/ml for (3D) method. Two spectrofluorimetric methods were developed, one for determination of ALF in the presence of its oxidative degradation product and the other for its determination in the presence of its acid or alkaline degradation products. The first method was based on measuring the native fluorescence of ALF in deionized water using λexcitation 325.0 nm and λemission 390.0 nm. The linearity range was 50.0–750.0 ng/ml. This method was also used to determine ALF in human plasma with the aid of a suggested solid phase extraction method. The second method was used for determination of ALF via its acid degradation product. The method was based on the reaction of fluorescamine with the primary aliphatic amine group produced on the degradation product moiety. The reaction product was determined spectrofluorimetrically using λexcitation 380.0 nm and λemission 465.0 nm. The linearity range was 100.0–900.0 ng/ml. All methods were validated according to the International Conference on Harmonization (ICH) guidelines, and applied to bulk powder and pharmaceutical formulations.
- 6 December 2006
- Published by Wiley in Journal of Separation Science
- Vol. 29 (18) , 2716-2724
Validated HPLC and HPTLC stability‐indicating methods for determination of alfuzosin hydrochloride in bulk powder and pharmaceutical formulations
Two sensitive, selective, and precise stability‐indicating, high‐performance liquid chromatography and high‐performance thin‐layer chromatography methods have been developed for the determination of alfuzosin hydrochloride in the presence of its degradation products. Alfuzosin.HCl was subjected to stress alkaline, acidic, oxidative, thermal, and photo‐degradation. The drug could be well separated from the degradation products upon applying the two methods. Separation by HPLC was achieved using an Xterra RP18 column and acetonitrile/0.02 M KH2PO4 (pH = 3) in a ratio of 20:80 as mobile phase. The flow rate was 1 mL/min. The linearity range was 0.25 to 11 μg/mL with mean percentage recovery of 100.26 ± 1.54. The HPTLC method used ALUGRAM Nano‐SIL silica gel 60 F254 plates; the optimized mobile phase was methanol/ammonia (100:1.2). Quantitatively the spots were scanned densitometrically at 245 nm. A second order polynomial equation was used for the regression. The range was 0.5–7 μg/spot. The mean percentage recovery was 100.13 ± 1.67. Two main degradation products were obtained in most stress conditions, separated, and identified by FT‐IR and NMR spectral analysis, from which the degradation pathway was proposed. The two methods were validated according to the International Conference on Harmonization. In addition, the HPLC method was used to study the kinetics of alkaline and acid degradation of the drug.
- 6 December 2006
- Published by Wiley in Journal of Separation Science
- Vol. 29 (18) , 2716-2724
Validated HPLC and HPTLC stability‐indicating methods for determination of alfuzosin hydrochloride in bulk powder and pharmaceutical formulations
Two sensitive, selective, and precise stability‐indicating, high‐performance liquid chromatography and high‐performance thin‐layer chromatography methods have been developed for the determination of alfuzosin hydrochloride in the presence of its degradation products. Alfuzosin.HCl was subjected to stress alkaline, acidic, oxidative, thermal, and photo‐degradation. The drug could be well separated from the degradation products upon applying the two methods. Separation by HPLC was achieved using an Xterra RP18 column and acetonitrile/0.02 M KH2PO4 (pH = 3) in a ratio of 20:80 as mobile phase. The flow rate was 1 mL/min. The linearity range was 0.25 to 11 μg/mL with mean percentage recovery of 100.26 ± 1.54. The HPTLC method used ALUGRAM Nano‐SIL silica gel 60 F254 plates; the optimized mobile phase was methanol/ammonia (100:1.2). Quantitatively the spots were scanned densitometrically at 245 nm. A second order polynomial equation was used for the regression. The range was 0.5–7 μg/spot. The mean percentage recovery was 100.13 ± 1.67. Two main degradation products were obtained in most stress conditions, separated, and identified by FT‐IR and NMR spectral analysis, from which the degradation pathway was proposed. The two methods were validated according to the International Conference on Harmonization. In addition, the HPLC method was used to study the kinetics of alkaline and acid degradation of the drug.